Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Cantor Fitzgerald Reiterates Neutral on CRISPR Therapeutics
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
Apellis Stock Jumps as Rare Kidney Disease Therapy Succeeds in Trial
Intellia Therapeutics GAAP EPS of -$1.52 Misses by $0.29, Revenue of $6.96M Misses by $11.29M
Editas Medicine Analyst Ratings